107 related articles for article (PubMed ID: 12885492)
1. Mortality reduction by breast-cancer screening.
Voogd AC; Coebergh JW
Lancet; 2003 Jul; 362(9379):245-6. PubMed ID: 12885492
[No Abstract] [Full Text] [Related]
2. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.
Vervoort MM; Draisma G; Fracheboud J; van de Poll-Franse LV; de Koning HJ
Br J Cancer; 2004 Jul; 91(2):242-7. PubMed ID: 15213715
[TBL] [Abstract][Full Text] [Related]
3. Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.
Mullooly M; Pfeiffer RM; Nyante SJ; Heckman-Stoddard BM; Perloff M; Jatoi I; Brinton LA; Aiello Bowles EJ; Hoover RN; Glass A; Berrington de Gonzalez A; Sherman ME; Gierach GL
J Clin Oncol; 2016 Jun; 34(18):2093-7. PubMed ID: 27022110
[No Abstract] [Full Text] [Related]
4. Screening and breast cancer.
Smith DW
N Engl J Med; 2006 Feb; 354(7):767-9; author reply 767-9. PubMed ID: 16482677
[No Abstract] [Full Text] [Related]
5. Adjuvant treatment of breast cancer.
Akerley WL
R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
[No Abstract] [Full Text] [Related]
6. Breast cancer in older women: screening and selection of locoregional therapy.
Sener SF
Semin Surg Oncol; 1996; 12(5):328-31. PubMed ID: 8873320
[TBL] [Abstract][Full Text] [Related]
7. Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01).
Alliot C
Cancer; 2006 Jul; 107(1):215; author reply 215-6. PubMed ID: 16691577
[No Abstract] [Full Text] [Related]
8. [Breast cancer: increased incidence, decreased mortality].
Heinzl S
Med Monatsschr Pharm; 2005 Mar; 28(3):73. PubMed ID: 15794364
[No Abstract] [Full Text] [Related]
9. Efficacy of tamoxifen as treatment of breast cancer.
Powles TJ
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-48-S1-54. PubMed ID: 9045315
[TBL] [Abstract][Full Text] [Related]
10. Can mammographic densities predict effects of tamoxifen on the breast?
Ursin G; Pike MC; Spicer DV; Porrath SA; Reitherman RW
J Natl Cancer Inst; 1996 Jan; 88(2):128-9. PubMed ID: 8537975
[No Abstract] [Full Text] [Related]
11. Mortality reduction by breast-cancer screening.
Bonneux L
Lancet; 2003 Jul; 362(9379):245. PubMed ID: 12885491
[No Abstract] [Full Text] [Related]
12. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
13. The control of breast cancer: the role of tamoxifen.
Forbes JF
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-5-S1-19. PubMed ID: 9045316
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for older women with node-positive breast cancer.
Ginsburg D
CMAJ; 2001 Sep; 165(5):525, 527. PubMed ID: 11563200
[No Abstract] [Full Text] [Related]
15. Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update).
Levine M;
CMAJ; 2001 Jan; 164(2):213. PubMed ID: 11332317
[No Abstract] [Full Text] [Related]
16. Effect of screening and adjuvant therapy on mortality from breast cancer.
Berry DA; Cronin KA; Plevritis SK; Fryback DG; Clarke L; Zelen M; Mandelblatt JS; Yakovlev AY; Habbema JD; Feuer EJ;
N Engl J Med; 2005 Oct; 353(17):1784-92. PubMed ID: 16251534
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen in early breast cancer.
Arriagada R
Lancet; 1998 Aug; 352(9125):403-4. PubMed ID: 9717953
[No Abstract] [Full Text] [Related]
18. Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery.
Son HJ; Oh KK
AJR Am J Roentgenol; 1999 Oct; 173(4):905-9. PubMed ID: 10511146
[TBL] [Abstract][Full Text] [Related]
19. [Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial].
Delozier T; Switsers O; Génot JY; Ollivier JM; Héry M; Namer M; Frenay M; Kerbrat P; Julien JP; Naja A; Janvier M; Macé-Lesec'h J
Bull Cancer; 1997 Jan; 84(1):25-30. PubMed ID: 9180855
[TBL] [Abstract][Full Text] [Related]
20. The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy.
de Gelder R; Heijnsdijk EA; Fracheboud J; Draisma G; de Koning HJ
Int J Cancer; 2015 Jul; 137(1):165-72. PubMed ID: 25430053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
